Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Boucher

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Neuro-Oncology Advances|May 27, 2024
D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomideWilliam B McKean, Jingye Yang, Kenneth Boucher, et al.
Prostate Cancer and Prostatic Diseases|January 6, 2018
p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancerBenjamin L Maughan, Liana B Guedes, Kenneth Boucher, et al.
Plos One|September 16, 2020
Interventions for increasing colorectal cancer screening uptake among African-American men: A systematic review and meta-analysisCharles R Rogers, Phung Matthews, Lei Xu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 24, 2007
Clinical experience with the NCCN distress thermometer in breast cancer patientsMichele Dabrowski, Kenneth Boucher, John H Ward, et al.
BMC Research Notes|February 16, 2023
A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)Matthew Gumbleton, Stephanie Allan, Hannah Conway, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 18, 2012
Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experienceJason J Schwartz, Lisa Pappas, Heather F Thiesset, et al.
BMC Cancer|February 2, 2018
A statewide investigation of geographic lung cancer incidence patterns and radon exposure in a low-smoking populationJudy Y Ou, Brynn Fowler, Qian Ding, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 4, 2015
FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinomaKevin P Horn, Jeffrey T Yap, Neeraj Agarwal, et al.
Journal of Gastroenterology|June 27, 2019
Familial pancreatic cancer risk: a population-based study in UtahDivyanshoo R Kohli, Ken Robert Smith, Jathine Wong, et al.
JAMA Oncology|August 4, 2017
Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch SyndromeN Jewel Samadder, Ken Robert Smith, Jathine Wong, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Neuro-Oncology Advances|May 27, 2024
D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomideWilliam B McKean, Jingye Yang, Kenneth Boucher, et al.
Prostate Cancer and Prostatic Diseases|January 6, 2018
p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancerBenjamin L Maughan, Liana B Guedes, Kenneth Boucher, et al.
Plos One|September 16, 2020
Interventions for increasing colorectal cancer screening uptake among African-American men: A systematic review and meta-analysisCharles R Rogers, Phung Matthews, Lei Xu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 24, 2007
Clinical experience with the NCCN distress thermometer in breast cancer patientsMichele Dabrowski, Kenneth Boucher, John H Ward, et al.
BMC Research Notes|February 16, 2023
A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)Matthew Gumbleton, Stephanie Allan, Hannah Conway, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 18, 2012
Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experienceJason J Schwartz, Lisa Pappas, Heather F Thiesset, et al.
BMC Cancer|February 2, 2018
A statewide investigation of geographic lung cancer incidence patterns and radon exposure in a low-smoking populationJudy Y Ou, Brynn Fowler, Qian Ding, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 4, 2015
FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinomaKevin P Horn, Jeffrey T Yap, Neeraj Agarwal, et al.
Journal of Gastroenterology|June 27, 2019
Familial pancreatic cancer risk: a population-based study in UtahDivyanshoo R Kohli, Ken Robert Smith, Jathine Wong, et al.
JAMA Oncology|August 4, 2017
Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch SyndromeN Jewel Samadder, Ken Robert Smith, Jathine Wong, et al.
Pageof 6